BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22504414)

  • 1. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer.
    Guirado M; Gil H; Saenz-Lopez P; Reinboth J; Garrido F; Cozar JM; Ruiz-Cabello F; Carretero R
    Hum Immunol; 2012 Jun; 73(6):668-72. PubMed ID: 22504414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Toll-like receptor 10 and susceptibility to Crohn's disease independent of NOD2.
    Abad C; González-Escribano MF; Diaz-Gallo LM; Lucena-Soto JM; Márquez JL; Leo E; Crivell C; Gómez-García M; Martín J; Núñez-Roldán A; García-Lozano JR
    Genes Immun; 2011 Dec; 12(8):635-42. PubMed ID: 21716313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder.
    Koga F; Kawakami S; Fujii Y; Saito K; Ohtsuka Y; Iwai A; Ando N; Takizawa T; Kageyama Y; Kihara K
    Clin Cancer Res; 2003 Nov; 9(15):5501-7. PubMed ID: 14654529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population?
    Gangwar R; Ahirwar D; Mandhani A; Mittal RD
    Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology.
    Kutikhin AG
    Hum Immunol; 2011 Oct; 72(10):955-68. PubMed ID: 21745515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer.
    Chen YC; Giovannucci E; Kraft P; Lazarus R; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1982-9. PubMed ID: 17932345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of intron-1 haplotypes of the G protein beta 4 subunit gene--association with survival and progression in patients with urothelial bladder carcinoma.
    Riemann K; Struwe H; Eisenhardt A; Obermaier B; Schmid KW; Siffert W
    Pharmacogenet Genomics; 2008 Nov; 18(11):999-1008. PubMed ID: 18815590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
    Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
    BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population.
    Angeletti S; Galluzzo S; Santini D; Ruzzo A; Vincenzi B; Ferraro E; Spoto C; Lorino G; Graziano N; Calvieri A; Magnani M; Graziano F; Pantano F; Tonini G; Dicuonzo G
    Hum Immunol; 2009 Sep; 70(9):729-32. PubMed ID: 19397946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of laminin-5 gamma2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor receptor [corrected] and human epidermal growth factor receptor [corrected] 2.
    Kiyoshima K; Oda Y; Kinukawa N; Naito S; Tsuneyoshi M
    Hum Pathol; 2005 May; 36(5):522-30. PubMed ID: 15948119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
    Wermke M; Maiwald S; Schmelz R; Thiede C; Schetelig J; Ehninger G; Bornhäuser M; Wassmuth R
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1718-27. PubMed ID: 20541026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase-2 as a multifunctional molecule of which the expression is associated with adverse prognosis of patients with urothelial bladder carcinomas.
    Gakiopoulou H; Nakopoulou L; Siatelis A; Mavrommatis I; Panayotopoulou EG; Tsirmpa I; Stravodimos C; Giannopoulos A
    Clin Cancer Res; 2003 Nov; 9(15):5573-81. PubMed ID: 14654538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rsf-1/HBXAP overexpression is independent of gene amplification and is associated with poor outcome in patients with urinary bladder urothelial carcinoma.
    Liang PI; Wu LC; Sheu JJ; Wu TF; Shen KH; Wang YH; Wu WR; Shiue YL; Huang HY; Hsu HP; Chen YH; Chen LT; Li CF; Liao AC
    J Clin Pathol; 2012 Sep; 65(9):802-7. PubMed ID: 22685262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.
    Marcinek P; Jha AN; Shinde V; Sundaramoorthy A; Rajkumar R; Suryadevara NC; Neela SK; van Tong H; Balachander V; Valluri VL; Thangaraj K; Velavan TP
    PLoS One; 2013; 8(8):e73103. PubMed ID: 24015287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.